174 related articles for article (PubMed ID: 26124662)
21. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer.
Bharali DJ; Sudha T; Cui H; Mian BM; Mousa SA
Nanomedicine; 2017 Jan; 13(1):263-273. PubMed ID: 27565690
[TBL] [Abstract][Full Text] [Related]
23. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.
Gan H; Chen L; Sui X; Wu B; Zou S; Li A; Zhang Y; Liu X; Wang D; Cai S; Liu X; Liang Y; Tang X
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():395-403. PubMed ID: 30033270
[TBL] [Abstract][Full Text] [Related]
24. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
25. Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.
Abd Ellah NH; Abouelmagd SA
Expert Opin Drug Deliv; 2017 Feb; 14(2):201-214. PubMed ID: 27426638
[TBL] [Abstract][Full Text] [Related]
26. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
27. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.
Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ
J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479
[TBL] [Abstract][Full Text] [Related]
28. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery.
Mørch Ý; Hansen R; Berg S; Åslund AK; Glomm WR; Eggen S; Schmid R; Johnsen H; Kubowicz S; Snipstad S; Sulheim E; Hak S; Singh G; McDonagh BH; Blom H; de Lange Davies C; Stenstad PM
Contrast Media Mol Imaging; 2015; 10(5):356-66. PubMed ID: 25930237
[TBL] [Abstract][Full Text] [Related]
31. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes.
Thondawada M; Wadhwani AD; S Palanisamy D; Rathore HS; Gupta RC; Chintamaneni PK; Samanta MK; Dubala A; Varma S; Krishnamurthy PT; Gowthamarajan K
Drug Dev Ind Pharm; 2018 Jul; 44(7):1120-1129. PubMed ID: 29430979
[TBL] [Abstract][Full Text] [Related]
32. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
33. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
34. One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles.
Kao CH; Wang JY; Chuang KH; Chuang CH; Cheng TC; Hsieh YC; Tseng YL; Chen BM; Roffler SR; Cheng TL
Biomaterials; 2014 Dec; 35(37):9930-9940. PubMed ID: 25212525
[TBL] [Abstract][Full Text] [Related]
35. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
Wang T; Kievit FM; Veiseh O; Arami H; Stephen ZR; Fang C; Liu Y; Ellenbogen RG; Zhang M
World Neurosurg; 2013; 80(1-2):134-41. PubMed ID: 23298674
[TBL] [Abstract][Full Text] [Related]
36. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.
Kamaly N; Xiao Z; Valencia PM; Radovic-Moreno AF; Farokhzad OC
Chem Soc Rev; 2012 Apr; 41(7):2971-3010. PubMed ID: 22388185
[TBL] [Abstract][Full Text] [Related]
37. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
[TBL] [Abstract][Full Text] [Related]
38. GA-101, a third-generation, humanized and glyco-engineered anti-CD20 mAb for the treatment of B-cell lymphoid malignancies.
Robak T
Curr Opin Investig Drugs; 2009 Jun; 10(6):588-96. PubMed ID: 19513948
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol-modified poly(lactide-co-glycolide) nanoparticles for tumor-targeted drug delivery.
Lee JJ; Lee SY; Park JH; Kim DD; Cho HJ
Int J Pharm; 2016 Jul; 509(1-2):483-491. PubMed ID: 27286639
[TBL] [Abstract][Full Text] [Related]
40. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
